[go: up one dir, main page]

WO2009003010A3 - Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane, et articles médicaux enrobés d'organopolysiloxane contenant une solution de protéines - Google Patents

Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane, et articles médicaux enrobés d'organopolysiloxane contenant une solution de protéines Download PDF

Info

Publication number
WO2009003010A3
WO2009003010A3 PCT/US2008/068136 US2008068136W WO2009003010A3 WO 2009003010 A3 WO2009003010 A3 WO 2009003010A3 US 2008068136 W US2008068136 W US 2008068136W WO 2009003010 A3 WO2009003010 A3 WO 2009003010A3
Authority
WO
WIPO (PCT)
Prior art keywords
organopolysiloxane
protein
aggregation
evaluating
methods
Prior art date
Application number
PCT/US2008/068136
Other languages
English (en)
Other versions
WO2009003010A2 (fr
Inventor
John Frank Carpenter
Theodore Randolph
John Paul Gabrielson
Jean-Bernard Hamel
Original Assignee
Becton Dickinson Co
Univ Colorado At Denver And He
John Frank Carpenter
Theodore Randolph
John Paul Gabrielson
Jean-Bernard Hamel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co, Univ Colorado At Denver And He, John Frank Carpenter, Theodore Randolph, John Paul Gabrielson, Jean-Bernard Hamel filed Critical Becton Dickinson Co
Priority to EP08841038.6A priority Critical patent/EP2201380B1/fr
Priority to CN201610529593.XA priority patent/CN106443002A/zh
Priority to PCT/US2008/080721 priority patent/WO2009055427A2/fr
Priority to CN200880119613XA priority patent/CN101889209A/zh
Priority to US12/739,009 priority patent/US8633034B2/en
Priority to EP20100164045 priority patent/EP2237038B1/fr
Priority to JP2010531196A priority patent/JP5081976B2/ja
Priority to ES10164045.6T priority patent/ES2543735T3/es
Publication of WO2009003010A2 publication Critical patent/WO2009003010A2/fr
Publication of WO2009003010A3 publication Critical patent/WO2009003010A3/fr
Priority to JP2012154844A priority patent/JP5978034B2/ja
Priority to US14/139,604 priority patent/US20140110297A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/82—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/149—Optical investigation techniques, e.g. flow cytometry specially adapted for sorting particles, e.g. by their size or optical properties
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N2015/0092—Monitoring flocculation or agglomeration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Plasma & Fusion (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des procédés permettant d'évaluer ou d'inhiber l'agrégation d'une protéine dans une suspension aqueuse incluant un organopolysiloxane, et des articles médicaux enrobés d'un organopolysiloxane contenant une solution de protéines qui comprend un sucre et un tensioactif non ionique.
PCT/US2008/068136 2007-06-25 2008-06-25 Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane, et articles médicaux enrobés d'organopolysiloxane contenant une solution de protéines WO2009003010A2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
EP20100164045 EP2237038B1 (fr) 2007-10-22 2008-10-22 Articles médicaux revêtus d'organopolysiloxane contenant une solution de protéine et tensioactif non ionique
CN201610529593.XA CN106443002A (zh) 2007-10-22 2008-10-22 评价在含有机基聚硅氧烷的悬浮液中蛋白质聚集的方法
PCT/US2008/080721 WO2009055427A2 (fr) 2007-10-22 2008-10-22 Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane et articles médicaux recouverts d'un organopolysiloxane contenant une solution protéique
CN200880119613XA CN101889209A (zh) 2007-10-22 2008-10-22 评价在含有机基聚硅氧烷的悬浮液中蛋白质聚集的方法和用含蛋白质溶液的有机基聚硅氧烷涂布的医疗制品
US12/739,009 US8633034B2 (en) 2007-06-25 2008-10-22 Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution
EP08841038.6A EP2201380B1 (fr) 2007-10-22 2008-10-22 Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane et articles médicaux recouverts d'un organopolysiloxane contenant une solution protéique
JP2010531196A JP5081976B2 (ja) 2007-10-22 2008-10-22 オルガノポリシロキサンを含む懸濁液においてタンパク質の凝集を評価するための方法
ES10164045.6T ES2543735T3 (es) 2007-10-22 2008-10-22 Artículos médicos revestidos con organopolisiloxano que contienen una disolución de proteína y un tensioactivo no iónico
JP2012154844A JP5978034B2 (ja) 2007-10-22 2012-07-10 オルガノポリシロキサンを含む懸濁液においてタンパク質の凝集を評価するための方法、およびタンパク質溶液を含有する、オルガノポリシロキサンでコーティングされた医療用品
US14/139,604 US20140110297A1 (en) 2007-06-25 2013-12-23 "Medical Articles Coated With Organopolysiloxane Containing a Protein Solution"

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93717907P 2007-06-25 2007-06-25
US60/937,179 2007-06-25

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US12/739,009 Continuation-In-Part US8633034B2 (en) 2007-06-25 2008-10-22 Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution
US12/739,009 Division US8633034B2 (en) 2007-06-25 2008-10-22 Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution
PCT/US2008/080721 Continuation-In-Part WO2009055427A2 (fr) 2007-06-25 2008-10-22 Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane et articles médicaux recouverts d'un organopolysiloxane contenant une solution protéique

Publications (2)

Publication Number Publication Date
WO2009003010A2 WO2009003010A2 (fr) 2008-12-31
WO2009003010A3 true WO2009003010A3 (fr) 2009-02-12

Family

ID=40186268

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/068136 WO2009003010A2 (fr) 2007-06-25 2008-06-25 Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane, et articles médicaux enrobés d'organopolysiloxane contenant une solution de protéines

Country Status (1)

Country Link
WO (1) WO2009003010A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8633034B2 (en) 2007-06-25 2014-01-21 Becton, Dickinson And Company Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution
US8802603B2 (en) 2010-06-17 2014-08-12 Becton, Dickinson And Company Medical components having coated surfaces exhibiting low friction and low reactivity
TWI669129B (zh) 2014-12-23 2019-08-21 德商梅茲製藥有限兩合公司 預填充式玻璃容器及其套組與使用
TWI728964B (zh) 2015-02-03 2021-06-01 德商梅茲製藥有限兩合公司 預填充式塑膠注射器及其套組與使用
CN107063940B (zh) 2016-02-10 2019-10-18 贝克顿迪金森法国公司 用于评价基于蛋白质的制剂的稳定性的方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525084B2 (en) * 1998-07-23 2003-02-25 Novo Nordisk A/S Stable pharmaceutical formulation
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US6638519B1 (en) * 1999-11-08 2003-10-28 L'oreal Composition for topical application comprising a sugar and its cosmetic uses
US20050053598A1 (en) * 2003-02-10 2005-03-10 Burke David J. Immunoglobulin formulation and method of preparation thereof
US20050123947A1 (en) * 1997-09-23 2005-06-09 California Institute Of Technology Methods and systems for molecular fingerprinting
US20060051353A1 (en) * 2004-05-14 2006-03-09 Jean-Frederic Colombel Methods and compositions to evaluate antibody treatment response

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123947A1 (en) * 1997-09-23 2005-06-09 California Institute Of Technology Methods and systems for molecular fingerprinting
US6525084B2 (en) * 1998-07-23 2003-02-25 Novo Nordisk A/S Stable pharmaceutical formulation
US6638519B1 (en) * 1999-11-08 2003-10-28 L'oreal Composition for topical application comprising a sugar and its cosmetic uses
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US20050053598A1 (en) * 2003-02-10 2005-03-10 Burke David J. Immunoglobulin formulation and method of preparation thereof
US20060051353A1 (en) * 2004-05-14 2006-03-09 Jean-Frederic Colombel Methods and compositions to evaluate antibody treatment response

Also Published As

Publication number Publication date
WO2009003010A2 (fr) 2008-12-31

Similar Documents

Publication Publication Date Title
WO2009055427A3 (fr) Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane et articles médicaux recouverts d'un organopolysiloxane contenant une solution protéique
WO2009158015A3 (fr) Antagonistes d’actriib et utilisations pour augmenter les taux d’érythrocytes
IL183249A0 (en) Packaging articles, films and methods that promote or preserve the desirable color of meat
WO2008076437A3 (fr) Antagonistes de l'activine-actrii et ses utilisations pour accroître les niveaux de globules rouges
ME02268B (fr) Processus de préparation d'électrodes modifiées, électrodes préparées avec ce processus, et biocapteurs enzymatiques comportant ces électrodes
EP2253227A4 (fr) Agent de renforcement de salinité et aliment ou boisson le contenant
IL195645A0 (en) Pullulan film, edible articles incorporating the same and methods for making the same
EP2447274A3 (fr) Composants oligomères et procédés
EP2263477A4 (fr) Agent de renforcement de goût salé et aliment ou boisson le contenant
WO2007109221A3 (fr) Methodes de reduction de l'agregation des proteines
EP2789246A4 (fr) Agent améliorant le goût et aliment ou boisson le contenant
WO2007126824A3 (fr) Procédés et systèmes de stérilisation
WO2010066012A3 (fr) Nutriment contenant des arabinoxylanes et des oligosaccharides
WO2007019176A3 (fr) Concentres de proteines de mais
CL2014001100A1 (es) Formulacion enzimatica liquida que comprende por lo menos una enzima para el entrecruzamiento y/o modificacion de proteinas lacteas en suspension de poliol-agua que contiene desde 25 a 100% (p/p) de poliol y que tiene un valor de ph dentro de la escala de 4,4 a 5,1; y metodo para preparar la formulacion.
EP2062861A4 (fr) Préproduction dépourvue de condensation, articles dépourvus de condensation et fluide de revêtement pour les articles
WO2009114475A3 (fr) Compositions comprenant de la pcsk9 humaine et un siarn d’apolipoprotéine b, et procédés d’utilisation de celles-ci
IL215592A (en) Compounds, preparations containing them and their uses in the treatment or prevention of conditions in the eyes
ZA200806998B (en) Agent enriched nanoparticles based on hydrophilic proteins
EP2361233A4 (fr) Produits à base de terre à diatomées contenant des taux réduits de métaux solubles, procédés de réduction des taux de métaux solubles dans des produits à base de terre à diatomées et procédés d'utilisation de ces produits
EP2335665A4 (fr) Article de gestion liquidienne et article vestimentaire le comprenant
WO2009003010A3 (fr) Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane, et articles médicaux enrobés d'organopolysiloxane contenant une solution de protéines
WO2007016195A3 (fr) Emballage jetable d'aliments pour bebes
WO2009064681A3 (fr) Compositions pharmaceutiques
EP1980258A4 (fr) Composition ayant un effet d'abaissement de la pression sanguine et/ou d'inhibition de l'augmentation de la pression sanguine, et aliment et boisson la contenant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08771891

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08771891

Country of ref document: EP

Kind code of ref document: A2